Related Experiment Videos

Dihydropiridinic Calcium-Channel Antagonists in the 2007 ESH/ESC Hypertension Guidelines

Giuseppe Mancia1

  • 1Clinica Medica, Dipartimento di Medicina Clinica e Prevenzione, University of Milano-Bicocca, Ospedale San Gerardo di Monza, Monza, Monza, Milan, Italy, giuseppe.mancia@unimib.it.

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|January 22, 2013
PubMed

Insights

Lowering blood pressure is key for antihypertensive treatment benefits. Calcium-channel antagonists (CCAs) are vital for managing hypertension and reducing cardiovascular risks, especially in high-risk patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Antihypertensive treatment benefits are largely derived from blood pressure reduction.
  • Target blood pressure is generally <140/90 mmHg, with lower goals for high-risk individuals.

Purpose of the Study:

  • To highlight the importance of calcium-channel antagonists (CCAs) in modern antihypertensive therapy.
  • To emphasize the role of CCAs in cardiovascular risk reduction and prevention.

Main Methods:

  • Review of clinical trial evidence on CCAs.
  • Analysis of CCA properties in monotherapy and combination therapy.
  • Evaluation of CCA effects on subclinical organ damage, particularly atherosclerosis.

Main Results:

  • CCAs effectively lower blood pressure in monotherapy and combination therapy.
  • Clinical trials demonstrate CCA-induced reduction in cardiovascular morbidity and mortality.
  • CCAs exhibit specific protective effects against atherosclerosis, a key factor in hypertension-related outcomes.

Conclusions:

  • CCAs are essential antihypertensive drugs due to their efficacy, safety profile, and organ-protective properties.
  • The use of CCAs aligns with contemporary cardiovascular prevention strategies aimed at delaying irreversible high-risk progression.
  • Optimizing blood pressure control with CCAs is crucial for managing hypertension and preventing cardiovascular events.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...